NGEN-Enzy LP is a private equity fund based in New York, New York. According to its most recent Form D, filed Sep 3, 2024, it has sold $21,554,508 of interests to 7 investors since its first sale in Jan 2024. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Peter Grubstein; Rosemary Ripley; NGEN Enzymedica LLC.
- Total raised
- $21,554,508Cumulative sales reported on Form D
- Investors
- 7
- First sale
- Jan 4, 2024
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Peter Grubstein; Rosemary Ripley; NGEN Enzymedica LLC
- Latest Form D
- Sep 3, 2024
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about NGEN-Enzy LP
What is the minimum investment for NGEN-Enzy LP?
NGEN-Enzy LP's latest Form D, filed Sep 3, 2024, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in NGEN-Enzy LP?
NGEN-Enzy LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has NGEN-Enzy LP raised?
NGEN-Enzy LP reports $21,554,508 sold from 7 investors on its Form D filed Sep 3, 2024. This is cumulative sales since the offering began, not current assets or performance.
Where is NGEN-Enzy LP based?
NGEN-Enzy LP is based in New York, New York.
When did NGEN-Enzy LP launch?
NGEN-Enzy LP reports its first sale in Jan 2024.
Size compared with every private equity fund
Raised more than 63% of the 3,665 private equity funds based in New York, and more than 53% of all 8,896 that report sales.